United States Market Report for Orthopedic Growth Factor 2017 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "US Market Report for Orthopedic Growth Factor 2017 - MedCore" report to their offering.

The U.S. market reacted strongly to public opinion on the backlash of product INFUSE® for its performance. Initially approved for spinal fusion in 2001, INFUSE® was subsequently approved for tibial fractures in 2004, then for dental operations in 2007. Lawsuits have accused Medtronic of hiding side effects and promoting unapproved use. The decline seen in unit sales in 2013 can be attributed to the controversy and lawsuits surrounding the misuse of INFUSE® for unapproved indications in the spine.

Key Topics Covered:

1. Research Methodology

2. Disease Overview

2.1 Basic Anatomy

2.1.1 Osteology And Musculoskeletal System

2.2 Disease Pathology And Disorders

2.2.1 General Diagnostic

2.2.2 Osteoporosis

2.2.3 Osteoarthritis

2.2.4 Indication For Bone Graft Procedure

2.2.5 Indication For Cartilage Repair

2.2.6 Degenerative Disc Disease

2.3 Patient Demographics

2.3.1 General Statistics

3. Product Assessment

3.1 Product Portfolios

3.1.1 Growth Factors

3.1.1.1 Other Products

3.2 Regulatory Issues And Recalls

3.2.1 Growth Factors

3.3 Clinical Trials

3.3.1 Growth Factors

4. Orthopedic Growth Factor Market

4.1 Introduction

4.1.1 Bmp-2 (Medtronic)

4.1.2 Pdgf-Bb (Wright Medical)

4.1.3 Bmp-7 (Olympus Biomaterials)

4.3 Market Analysis And Forecast

4.4 Drivers And Limiters

4.5 Competitive Market Share Analysis

Companies Mentioned

- Medtronic

- Genzyme

- DePuy Synthes

- Anika Therapeutics

- Ferring Pharmaceuticals

- Stryker

- NuVasive

- Bioventus

- Zimmer Biomet

- Integra LifeSciences

- RTI Surg

For more information about this report visit http://www.researchandmarkets.com/research/l9tldw/us_market_report

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Musculoskeletal Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Musculoskeletal Disorders Drugs